q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

April 2016 summary of the new medications added to Medicare Part D plan formularies (drug lists)

Category: Monthly Formulary Changes
Published: Apr, 25 2016 03:04:42
< Previous
Next >
The April, 2016 Medicare Part D plan formulary data (or drug lists) includes the addition of 56 new National Drug Codes (NDC) to the Medicare Part D program.  These NDCs represent 38 different drugs, many with multiple strengths. Lincomycin HCl the generic for Lincocin was added to many 2016 Medicare Part D formularies.  As a note, the May 2016 Medicare Part D plan formulary data included no new drug codes and only minor additions and deletions from plan formularies.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is as follows:

Reason for NDC Addition Occurrences
New Delivery Form and Strength 3
New Drug 12
New Drug and Strength 19
New Manufacturer 1
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 10
New Manufacturer, Strength and Delivery Form
 1
New Strength 9
Total New NDCs 56

The following chart details the 56 new manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
00378395109 ATORVASTATIN 20 MG TABLET New Strength
00093202723 AZITHROMYCIN 100 MG/5 ML SUSP New Manufacturer and Strength
68180086611 BLISOVI FE 1.5-30 TABLET New Strength
42543043401 CARISOPRODOL 250 MG TABLET New Manufacturer and Strength
00006095154 COZAAR 25 MG TABLET New Strength
59212000101 DIBENZYLINE 10 MG CAPSULE New Drug
59212000301 DYRENIUM 100 MG CAPSULE New Drug and Strength
59212000201 DYRENIUM 50 MG CAPSULE New Drug and Strength
00006394132 EMEND 150 MG VIAL New Delivery Form and Strength
00003452211 EMPLICITI 400 MG VIAL New Strength
50222030260 ENSTILAR 0.005%-0.064% FOAM New Drug
62756043288 EXTENDED PHENYTOIN SODIUM CAPSULES 300 MG New Drug
43068010402 FANAPT 4 MG TABLET New Manufacturer and Strength
53489067707 FENOFIBRIC ACID 35 MG TABLET [TRILIPIX] New Manufacturer and Strength
00597005801 FLOMAX 0.4 MG CAPSULE New Drug
00074433902 HUMIRA 40 MG/0.8 ML PEN New Strength
00074379903 HUMIRA PEDIATRIC CROHN'S START New Delivery Form and Strength
00074379906 HUMIRA PEDIATRIC CROHN'S START New Delivery Form and Strength
50458060601 INVEGA TRINZA 273 MG/0.875 ML New Drug and Strength
50458060701 INVEGA TRINZA 410 MG/1.315 ML New Drug and Strength
50458060801 INVEGA TRINZA 546 MG/1.75 ML New Drug and Strength
50458060901 INVEGA TRINZA 819 MG/2.625 ML New Drug and Strength
68180090311 KAITLIB FE CHEWABLE TABLET New Drug
59212024555 LANOXIN 187.5 MCG TABLET New Manufacturer and Strength
39822035001 Lincomycin hcl 600 mg/2 ml vl [Lincocin] New Drug
69238125206 LOPREEZA 0.5 MG-0.1 MG TABLET New Drug and Strength
69238125106 LOPREEZA 1 MG-0.5 MG TABLET New Drug and Strength
45963020011 METHYLPHENIDATE LA 20 MG CAP New Manufacturer and Strength
76431021001 MYALEPT 11.3 MG (5 MG/ML) VIAL New Drug
00378727753 NORG-EE 0.18-0.215-0.25/0.025 New Manufacturer and Strength
60505036302 OFLOXACIN 0.3% EAR DROPS New Manufacturer and Delivery Form
51079052501 ONDANSETRON HCL 8 MG TABLET New Manufacturer
62756029988 PHENYTOIN SODIUM EXT 200 MG CAP New Strength
00641610525 ROBINUL 0.4 MG/2 ML VIAL New Manufacturer, Strength and Delivery Form
63481022906 SUMAVEL DOSEPRO 4 MG/0.5 ML New Strength
52244010010 THEO-24 ER 100 MG CAPSULE New Manufacturer and Strength
52244020010 THEO-24 ER 200 MG CAPSULE New Manufacturer and Strength
52244030010 THEO-24 ER 300 MG CAPSULE New Manufacturer and Strength
25021082406 Topotecan hcl 4 mg vial New Drug
00781406215 TRI-LO-ESTARYLLA TABLET New Drug
00093214028 TRI-LO-SPRINTEC TABLET New Drug
66215061006 UPTRAVI 1,000 MCG TABLET New Drug and Strength
66215061206 UPTRAVI 1,200 MCG TABLET New Drug and Strength
66215061406 UPTRAVI 1,400 MCG TABLET New Drug and Strength
66215061606 UPTRAVI 1,600 MCG TABLET New Drug and Strength
66215060214 UPTRAVI 200 MCG TABLET New Drug and Strength
66215062820 UPTRAVI 200-800 TITRATION PACK New Drug and Strength
66215060406 UPTRAVI 400 MCG TABLET New Drug and Strength
66215060606 UPTRAVI 600 MCG TABLET New Drug and Strength
66215060806 UPTRAVI 800 MCG TABLET New Drug and Strength
61874010060 VIBERZI 100 MG TABLET New Drug and Strength
61874007560 VIBERZI 75 MG TABLET New Drug and Strength
00781557515 VIENVA-28 TABLET New Drug
00456110130 VIIBRYD 10-20 MG STARTER PACK New Strength
00173034442 ZANTAC 150 MG TABLET New Strength
00006307402 ZEPATIER 50-100 MG TABLET New Drug


You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.